|

ChAracterization of Patients and Treatment OUtcomes in Severe Tricuspid Regurgitation

RECRUITINGSponsored by Medical University of Warsaw
Actively Recruiting
SponsorMedical University of Warsaw
Started2023-11-14
Est. completion2027-11-14
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06838611

Summary

The goal of this observational study is to characterize the population of patients qualified for transcatheter tricuspid valve interventions (TTVI). It is expected to: * Describe the profile of patients qualified for TTVI * Establish the most common causes for disqualification from TTVI * Evaluate the immediate and long-term efficacy of TTVI * Evaluate TTVI safety Participants will undergo a standard qualification procedure for TTVI and then will be subject to a follow-up consisting of clinical examination, echocardiography and laboratory testing.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* tricuspid regurgitation
* qualification for transcatheter tricuspid valve intervention

Exclusion Criteria:

* tricuspid regurgitation qualified for surgical treatment
* concomitant left heart valve disease qualified for surgical treatment
* multivessel coronary artery disease qualified for coronary artery bypass grafting
* lack of patient's consent to enter the registry

Conditions4

Heart DiseaseHeart FailureTricuspid RegurgitationValve Heart Disease

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.